- Motley Fool•2 hours ago
A post-presidential election rally ahead of positive interim results released by a collaboration partner helped propel Celgene's shares higher.
- Business Wire•3 hours agoAcceleron and Celgene Announce Preliminary Results from an Investigator Initiated Phase 2 Study of Sotatercept in Myelofibrosis at the 58th Annual Meeting of the American Society of Hematology
Acceleron Pharma Inc. and Celgene Corporation , today announced preliminary results from an ongoing investigator initiated Phase 2 study with investigational drug sotatercept in patients with myelofibrosis at the 58th Annual Meeting of the American Society of Hematology in San Diego, California.
- TheStreet.com•20 hours ago
While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||118.00 x 500|
|Ask||118.89 x 200|
|Day's Range||117.07 - 118.28|
|52 Week Range||93.05 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||44.53|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|